1 |
Shanahan F. 2002. Gut flora in gastrointestinal disease. Eur. J. Surg. Suppl. 587: 47-52.
|
2 |
Jang SE, Han MJ, Kim SY, Kim DH. 2014. Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. Int. Immunopharmacol. 21: 186-192.
DOI
|
3 |
Chandran P, Satthaporn S, Robins A, Eremin O. 2003. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). Surgeon 1: 63-75.
DOI
|
4 |
Aderem A, Ulevitch RJ. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
DOI
|
5 |
Min SW, Ryu SN, Kim DH. 2010. Anti-inflammatory effects of black rice, cyanidin-3-O- -D-glycoside, and its metabolites, cyanidin and protocatechuic acid. Int. Immunopharmacol. 10: 959-966.
DOI
|
6 |
Hutchison S, Choo-Kang BS, Bundick RV, Leishman AJ, Brewer JM, McInnes IB, et al. 2008. Tumour necrosis factoralpha blockade suppresses murine allergic airways inflammation. Clin. Exp. Immunol. 151: 114-122
DOI
|
7 |
Lee IA, Park YJ, Joh EH, Kim DH. 2011. Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR) 4 on macrophages. J. Agric. Food Chem. 59: 13165-13172.
DOI
|
8 |
Collins MP, Gibson GR. 1999. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69: 1052S-1057S.
DOI
|
9 |
Aggarwal J, Swami G, Kumar M. 2013. Probiotics and their effects on metabolic diseases: an update. J. Clin. Diagn. Res. 7: 173-177.
DOI
|
10 |
Romeo J, Nova E, Warnberg J, Gomez-Martinez S, Diaz Ligia LE, Marcos A. 2010. Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages. Nutr. Hosp. 25: 341-349.
|
11 |
Peran L, Sierra S, Comalada M, Lara-Villoslada F, Bailon E, Nieto A, et al. (2007). A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br. J. Nutr. 97: 96-103.
DOI
|
12 |
Okada Y, Tsuzuki Y, Takeshi T, Furuhashi H, Higashiyama M, Watanabe C, et al. 2018. Novel probiotics isolated from a Japanese traditional fermented food, Funazushi, attenuates DSS-induced colitis by increasing the induction of high integrin -expressing dendritic cells. J. Gastroenterol. 53: 407-418.
DOI
|
13 |
Bellavia M, Rappa F, Lo Bello M, Brecchia G, Tomasello G, Leone A, et al. 2014. Lactobacillus casei and Bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice. J. Biol. Regul. Homeost. Agents. 28: 251-261.
|
14 |
Jang SE, Jeong JJ, Kim JK, Han MJ, Kim DH. 2018. Simultaneous amelioratation of colitis and liver injury in mice by Bifidobacterium longum LC67 and Lactobacillus plantarum LC27. Sci. Rep. 8: 7500.
DOI
|
15 |
Jang SE, Hyun YJ, Oh YJ, Choi KB, Kim T, Yeo IH, et al. 2011. Adhesion activity of Lactobacillus plantarum PM 008 isolated from Kimchi on the intestine of mice. J. Bacteriol. Virol. 41: 83-90.
DOI
|
16 |
Kos B, Suskovic J, Vukovic S, Simpraga M, Frece J, Matosic S. 2003. Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J. Appl. Microbiol. 94: 981-987.
DOI
|
17 |
Lee KW, Park JY, Sa HD, Jeong JH, Jin DE, Heo HJ, et al. 2014. Probiotic properties of Pediococcus strains isolated from Jeotgals, salted and fermented Korean sea-food. Ananerobe 28: 199-206.
DOI
|
18 |
Lim SM, Jeong JJ, Jang SE, Han MJ, Kim DH. 2016. A mixture of the probiotic strains Bifidobacterium longum CH57 and Lactobacillus brevis CH23 ameliorates colitis in mice by inhibiting macrophage activation and restoring the Th17/Treg balance. J. Funct. Foods. 27: 295-309.
DOI
|
19 |
Kwon KH, Murakami A, Hayashi R, Ohigashi H. 2005. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis. Biochem. Biophys. Res. Commun. 337: 647-654.
DOI
|
20 |
Ljungh A, Wadstrom T. 2006. Lactic acid bacteria as probiotics. Curr. Issues Intestinal Microbiol. 7: 73-90.
|
21 |
Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. 2000. Probiotic bacteria: safety, functional and technological properties. J. Biotechnol. 84: 197-215.
DOI
|
22 |
Iyer SS, Cheng G. 2012. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit. Rev. Immunol. 32: 23-63.
DOI
|
23 |
Fiorucci S, Mencarelli A, Palazzetti B, Sprague AG, Distrutti E, Morelli A, et al. 2002. Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis. Immunity 17: 769-780.
DOI
|
24 |
Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Buschenfelde, KH, et al. 1997. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27: 1743-1750.
DOI
|
25 |
Fiorucci S, Mencarelli A, Palazzetti B, Distrutti E, Vergnolle N, Hollenberg MD, et al. 2001. Proteinase-activated receptor (PAR)-2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc. Natl. Acad. Sci. USA 98: 13936-13941.
DOI
|
26 |
Barens PJ, Karin M. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071.
DOI
|
27 |
Jang SE, Hyam SR, Jeong JJ, Han MJ, Kim DH. 2013. Penta-O-galloyl- -D-glucose ameliorates inflammation by inhibiting MyD88/ and MyD88/MAPK signalling pathways. Br. J. Pharmacol. 170: 1078-1091.
DOI
|
28 |
Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. 1995. Transcriptional regulation of endothelial cell adhesion molecules: and cytokine inducible enhancers. FASEB. J. 9: 899-909.
DOI
|
29 |
Yu YR, Rodriguez JR. 2017. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. Semin. Pediatr. Surg. 26: 349-355.
DOI
|
30 |
Chami B, Martin NJJ, Dennis JM, Witting PK. 2018. Myeloperoxidase in the inflamed colon: a novel target for treating inflammatory bowel disease. Arch. Biochem. Biophys. 645: 61-71.
DOI
|
31 |
Neuman MG, Nanau RM. 2012. Inflammatory bowel disease: role of diet, microbiota, life style. Trans. Res. 160: 29-44.
DOI
|